China NMPA Product Recall - Insulin pumps use disposable infusion tubing and needles

Medtronic (Shanghai) Management Co., Ltd., in conjunction with manufacturer Unimedical a/s, initiated a voluntary Class II recall for specific disposable infusion tubing and needles used with insulin pumps. This recall, formally reported on December 2, 2014, to the National Medical Products Administration (NMPA) through the Shanghai Municipal Food and Drug Administration, stemmed from an increasing trend of reported disconnection connectors in these vital medical devices. The affected products encompass various models, including MMT-series (e.g., MMT-368, MMT-371) and MiniMed Silhouette® and MiniMed Sure-T disposable infusion sets. The recall specifically targets products manufactured and sold after June 1, 2013, with significant quantities distributed in China. The primary issue, connector disconnection, posed a potential risk to patients relying on continuous insulin delivery. Medtronic (Shanghai) Management Co., Ltd. proactively implemented measures to remove these products from circulation, ensuring patient safety and adherence to the NMPA's medical device regulatory framework. This action underscores the critical role of post-market vigilance and decisive responses to product safety concerns in the medical industry.